Home › Compare › RNUGF vs RYLD

RNUGF vs RYLD: Dividend Comparison 2026

RNUGF yields 181818.18% · RYLD yields 4.00%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RNUGF wins by $1.8951031795759825e+29M in total portfolio value
10 years
RNUGF
RNUGF
● Live price
181818.18%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.8951031795759825e+29M
Annual income
$189,305,502,041,192,720,000,000,000,000,000,000.00
Full RNUGF calculator →
RYLD
RYLD
● Live price
4.00%
Share price
$50.00
Annual div
$2.00
5Y div CAGR
5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.0K
Annual income
$899.19
Full RYLD calculator →

Portfolio growth — RNUGF vs RYLD

📍 RNUGF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRNUGFRYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RNUGF + RYLD cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
RNUGF pays
RYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RNUGF
Annual income on $10K today (after 15% tax)
$15,454,545.45/yr
After 10yr DRIP, annual income (after tax)
$160,909,676,735,013,800,000,000,000,000,000,000.00/yr
RYLD
Annual income on $10K today (after 15% tax)
$340.00/yr
After 10yr DRIP, annual income (after tax)
$764.31/yr
At 15% tax rate, RNUGF beats the other by $160,909,676,735,013,800,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RNUGF + RYLD for your $10,000?

RNUGF: 50%RYLD: 50%
100% RYLD50/50100% RNUGF
Portfolio after 10yr
$9.475515897879912e+28M
Annual income
$94,652,751,020,596,360,000,000,000,000,000,000.00/yr
Blended yield
99.89%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RNUGF buys
0
RYLD buys
0
No recent congressional trades found for RNUGF or RYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRNUGFRYLD
Forward yield181818.18% ✓4.00%
Annual dividend / share$2.00$2.00
Payout ratio50%50%
1-year div growth0%5% ✓
5-year div CAGR0%5% ✓
Portfolio after 10y$1.8951031795759825e+29M$28.0K ✓
Annual income after 10y$189,305,502,041,192,720,000,000,000,000,000,000.00 ✓$899.19
Total dividends collected$1.8949690612486723e+29M$6.4K ✓
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: RNUGF vs RYLD ($10,000, DRIP)

YearRNUGF PortfolioRNUGF Income/yrRYLD PortfolioRYLD Income/yrGap
1← crossover$18,192,518$18,181,818.18$11,120$420.00+$18.18M → RNUGF
2$30,932,835,887$30,913,369,892.64$12,357$458.31+$30932.82M → RNUGF
3$49,156,619,660,049$49,123,521,525,649.34$13,721$499.76+$49156619.65M → RNUGF
4$73,009,768,971,452,110$72,957,171,388,415,860.00$15,227$544.58+$73009768971.44M → RNUGF
5$101,348,671,691,011,770,000$101,270,551,238,212,300,000.00$16,885$593.02+$101348671691011.75M → RNUGF
6$131,490,628,941,834,950,000,000$131,382,185,863,125,600,000,000.00$18,713$645.34+$131490628941834960.00M → RNUGF
7$159,445,709,700,484,420,000,000,000$159,305,014,727,516,640,000,000,000.00$20,724$701.81+$159445709700484431872.00M → RNUGF
8$180,706,560,655,892,340,000,000,000,000$180,535,953,746,512,850,000,000,000,000.00$22,938$762.73+$1.8070656065589233e+23M → RNUGF
9$191,416,744,304,199,340,000,000,000,000,000$191,223,388,284,297,560,000,000,000,000,000.00$25,372$828.41+$1.9141674430419936e+26M → RNUGF
10$189,510,317,957,598,240,000,000,000,000,000,000$189,305,502,041,192,720,000,000,000,000,000,000.00$28,047$899.19+$1.8951031795759825e+29M → RNUGF

RNUGF vs RYLD: Complete Analysis 2026

RNUGF — Stock

ReNeuron Group plc researches, develops, and commercializes cell-based therapies in the United Kingdom. The company engages in the development of CTX stem cell therapy candidate for treating stroke disability; and human retinal progenitor cell therapy that is in Phase 2 clinical trial for treating retinitis pigmentosa, a blindness-causing disease. It also develops CTX-derived exosomes that are in the pre-clinical stage, which are Nano-sized packages of information released by CTX cells. In addition, the company licenses ReNcell products. It has a collaboration agreement with University College London to conduct research into the generation of immune cells from induced pluripotent stem cells for anti-cancer cell therapies. The company was founded in 1997 and is headquartered in Pencoed, the United Kingdom.

Full RNUGF Calculator →

RYLD — ETF

RYLD is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in RYLD shares.

Full RYLD Calculator →
📬

Get this RNUGF vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RNUGF vs SCHDRNUGF vs JEPIRNUGF vs ORNUGF vs KORNUGF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.